Vanadium: Possible Use in Cancer Chemoprevention and Therapy
DOI:
https://doi.org/10.6000/1929-2279.2014.03.02.3Keywords:
Vanadium, vanadium-containing compounds, anti-cancer activity, chemoprevention, anti-carcinogenic effect, apoptosis, antiproliferative activity.Abstract
Vanadium belongs among the microelements and plays a role in human nutrition. However, it is not regarded as an essential micronutrient. Vanadium affects various biochemical processes and when present in the body, it is capable of interacting with a notable number of enzymes e.g. protein kinases, phosphatases, ATPases, peroxidases, ribonucleases, oxidoreductases and others. It is documented in scientific literature that vanadium takes part in biochemical processes in mammals. Vanadium is not carcinogenic but its presence in cancer cells and its interactions with many key enzymatic processes results in modified expression of p53 and Bax and in down regulation of Bcl2 proteins and in antiproliferative activity. Anti-carcinogenic and anticancer effects of vanadium in various forms have been demonstrated using in vitro and in vivo experiments. Presently, epidemiologic and clinical studies are necessary for developing a clinically useful, vanadium-based anticancer agent/drug for chemoprevention of cancer. This review summarizes recent scientific information on the role and potential use of vanadium in cancer chemoprevention and cancer therapy.
References
Schwarz K, Milne DB. Growth effects of vanadium in the rat. Science 1971; 174: 426-8. http://dx.doi.org/10.1126/science.174.4007.426
Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003; 26:
-94. http://dx.doi.org/10.2337/diacare.26.4.1277
Talbott SM, Hughes K. Vanadium. The Health Professional's Guide to Dietary Supplements. Lippincott Williams & Wilkins. 2007; pp. 419-22.
Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese non-diabetic subjects. Diabetes 1996; 45: 659-66. http://dx.doi.org/10.2337/diab.45.5.659
Goldfine AB, Patti ME, Zuberi L, et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism 2000; 49: 400-10. http://dx.doi.org/10.1016/S0026-0495(00)90418-9
Roschin AV. Toxicology of vanadium compounds used in modern industry. Gig Sanit (Water Res) 1967; 32: 26-32.
Assem FL, Levy LS. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J Toxicol Environ Health B Crit Rev 2009; 12: 289-306. http://dx.doi.org/10.1080/10937400903094166
Bishayee A, Waghray A, Patel MA, Chatterjee M. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett 2010; 294: 1-12. http://dx.doi.org/10.1016/j.canlet.2010.01.030
Crans DC, Zhang B, Gaidamauskas E, Keramidas AD, Willsky GR, Roberts CR. Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution. Inorg Chem 2010; 49: 4245-56. http://dx.doi.org/10.1021/ic100080k
Ramos S, Duarte RO, Moura JJ, Aureliano M. Decavanadate interactions with actin: cysteine oxidation and vanadyl formation. Dalton Trans 2009; 38: 7985-94. http://dx.doi.org/10.1039/b906255f
Rodríguez-Mercado JJ, Mateos-Nava RA, Altamirano-Lozano MA. DNA damage induction in human cells exposed to vanadium oxides in vitro. Toxicol In Vitro 2011; 25: 1996-2002. http://dx.doi.org/10.1016/j.tiv.2011.07.009
Andrezalova L, Gbelcova H, Durackova Z. DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate hetero ligands. J Trace Elem Med Biol 2013; 27: 21-6. http://dx.doi.org/10.1016/j.jtemb.2012.04.007
Ramasarma T. In praise of H2O2, the versatile ROS, and its vanadium complexes. Toxicol Mech Methods 2012; 22: 336-46. http://dx.doi.org/10.3109/15376516.2012.666649
Badmaev V, Prakash S, Majeed M. Vanadium: a review of its potential role in the fight against diabetes. J Altern Complement Med 1999; 5: 273-91. http://dx.doi.org/10.1089/acm.1999.5.273
Rehder D. The potentiality of vanadium in medicinal applications. Future Med Chem 2012; 4: 1823-37. http://dx.doi.org/10.4155/fmc.12.103
Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C. Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem 2009; 103: 554-8. http://dx.doi.org/10.1016/j.jinorgbio.2008.12.003
Jacques-Camarena O, González-Ortiz M, Martínez-Abundis E, López-Madrueño JF, Medina-Santillán R. Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance. Ann Nutr Metab 2008; 53: 195-8. http://dx.doi.org/10.1159/000175844
Clancy HA, Sun H, Passantino L, Kluz T, Muñoz A, Zavadil J, Costa M. Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics 2012; 4: 784-93. http://dx.doi.org/10.1039/c2mt20074k
Rodríguez-Mercado JJ, Alvarez-Barrera L, Altamirano-Lozano MA. Chromosomal damage induced by vanadium oxides in human peripheral lymphocytes. Drug Chem Toxicol 2010; 33: 97-102. http://dx.doi.org/10.3109/01480540903176602
Leopardi P, Villani P, Cordelli E, Siniscalchi E, Veschetti E, Crebelli R. Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure. Toxicol Lett 2005; 158: 39-49. http://dx.doi.org/10.1016/j.toxlet.2005.02.009
Islam MK, Tsuboya C, Kusaka H, et al. Reduction of vanadium(V) to vanadium(IV) by NADPH, and vanadium(IV) to vanadium(III) by cysteine methyl ester in the presence of biologically relevant ligands. Biochim Biophys Acta 2007; 1770: 1212-8. http://dx.doi.org/10.1016/j.bbagen.2007.05.003
Ferrer EG, Williams PA, Baran EJ. On the interaction of oxovanadium (IV) with homocysteine. Biol Trace Elem Res 2005; 105: 53-8. http://dx.doi.org/10.1385/BTER:105:1-3:053
Cuesta S, Frances D, Garcia GB. ROS formation and antioxidant status in brain areas of rats exposed to sodium metavanadate. Neurotoxicol Teratol 2011; 33: 297-302. http://dx.doi.org/10.1016/j.ntt.2010.10.010
Shukla R, Barve V, Padhye S, Bhonde R. Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: a pragmatic therapeutic approach for diabetes. Biometals 2006; 19: 685-93. http://dx.doi.org/10.1007/s10534-006-9005-3
Gandara RM, Soares SS, Martins H, Gutierrez-Merino C, Aureliano M. Vanadate oligomers: in vivo effects in hepatic vanadium accumulation and stress markers. J Inorg Biochem 2005; 99: 1238-44. http://dx.doi.org/10.1016/j.jinorgbio.2005.02.023
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. Biochemical and medical importance of vanadium compounds. Acta Biochim Pol 2012; 59: 195-200.
Samanta S, Swamy V, Suresh D, et al. Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O(6)-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase down regulation and apoptotic induction. Mutat Res 2008; 650: 123-31. http://dx.doi.org/10.1016/j.mrgentox.2007.11.001
Yamaguchi T, Watanabe S, Matsumura Y, Tokuoka Y, Yokoyama A. Oxovanadium complexes with quinoline and pyridinone ligands: syntheses of the complexes and effect of alkyl chains on their apoptosis-inducing activity in leukemia cells. Bioorg Med Chem 2012; 20: 3058-64. http://dx.doi.org/10.1016/j.bmc.2012.02.063
Cui W, Cui H, Peng X, et al. Dietary vanadium induces lymphocyte apoptosis in the bursa of Fabricius of broilers. Biol Trace Elem Res 2012; 146: 59-67. http://dx.doi.org/10.1007/s12011-011-9215-6
Goncalves AP, Videira A, Soares P, Máximo V. Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR. Life Sci 2011; 89: 371-7. http://dx.doi.org/10.1016/j.lfs.2011.07.004
Meshkini A, Yazdanparast R. Chemosensitization of human leukemia K562 cells to taxol by a Vanadium-salen complex. Exp Mol Pathol 2010; 89: 334-42. http://dx.doi.org/10.1016/j.yexmp.2010.08.008
Zhao Y, Ye L, Liu H, et al. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress. J Inorg Biochem 2010; 104: 371-8. http://dx.doi.org/10.1016/j.jinorgbio.2009.11.007
Markopoulou S, Kontargiris E, Batsi C, et al. Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin. FEBS J 2009; 276: 3784-99. http://dx.doi.org/10.1111/j.1742-4658.2009.07093.x
Thompson HJ, Chasteen ND, Meeker LD. Dietary vanadyl(IV) sulfate inhibits chemically-induced mammary carcinogenesis. Carcinogenesis 1984; 5: 849-51. http://dx.doi.org/10.1093/carcin/5.6.849
Bishayee A, Oinam S, Basu M, Chatterjee M. Vanadium chemoprevention of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phase I and II xenobiotic metabolizing enzymes. Breast Cancer Res Treat 2000; 63: 133-45. http://dx.doi.org/10.1023/A:1006476003685
Ray RS, Basu M, Ghosh B, Samanta K, Chatterjee M. Vanadium, a versatile biochemical effector in chemical rat mammary carcinogenesis. Nutr Cancer 2005; 51: 184-96. http://dx.doi.org/10.1207/s15327914nc5102_9
Manna S, Das S, Chatterjee M, Janarthan M, Chatterjee M. Combined supplementation of vanadium and fish oil suppresses tumor growth, cell proliferation and induces apoptosis in DMBA-induced rat mammary carcinogenesis. J Cell Biochem 2011; 112: 2327-39. http://dx.doi.org/10.1002/jcb.23153
Tang LY, Su Y, He JR, et al. Urinary titanium and vanadium and breast cancer: a case-control study. Nutr Cancer 2012; 64: 368-76. http://dx.doi.org/10.1080/01635581.2012.654586
Chakraborty T, Chatterjee A, Saralaya MG, Chatterjee M. Chemopreventive effect of vanadium in a rodent model of chemical hepatocarcinogenesis: reflections in oxidative DNA damage, energy-dispersive X-ray fluorescence profile and metallothionein expression. J Biol Inorg Chem 2006; 11: 855-66. http://dx.doi.org/10.1007/s00775-006-0128-3
Chakraborty T, Chatterjee A, Rana A, Dhachinamoorthi D, Kumar PA, Chatterjee M. Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium on this process. Biochim Biophys Acta 2007; 1772: 48-59. http://dx.doi.org/10.1016/j.bbadis.2006.10.019
Chakraborty T, Swamy AH, Chatterjee A, Rana B, Shyamsundar A, Chatterjee M. Molecular basis of vanadium-mediated inhibition of hepatocellular preneoplasia during experimental hepatocarcinogenesis in rats. J Cell Biochem 2007; 101: 244-58. http://dx.doi.org/10.1002/jcb.21169
Ray RS, Ghosh B, Rana A, Chatterjee M. Suppression of cell proliferation, induction of apoptosis and cell cycle arrest: chemopreventive activity of vanadium in vivo and in vitro. Int J Cancer 2007; 120: 13-23. http://dx.doi.org/10.1002/ijc.22277
Ray RS, Rana B, Swami B, Venu V, Chatterjee M. Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line. Chem Biol Interact 2006; 163: 239-47. http://dx.doi.org/10.1016/j.cbi.2006.08.006
Clark O, Daga S, Stoker AW. Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence. Cancer Lett 2013; 328: 44-54. http://dx.doi.org/10.1016/j.canlet.2012.09.014
Havelek R, Siman P, Cmielova J, et al. Differences in vanadocene dichloride and cisplatin effect on MOLT-4 leukemia and human peripheral blood mononuclear cells. Med Chem 2012; 8: 615-21. http://dx.doi.org/10.2174/157340612801216364
Naso LG, Ferrer EG, Butenko N, et al. Antioxidant, DNA cleavage, and cellulareffects of silibinin and a new oxovanadium(IV)/silibinin complex. J Biol Inorg Chem 2011; 16: 653-68. http://dx.doi.org/10.1007/s00775-011-0769-8
Downloads
Published
How to Cite
Issue
Section
